Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 0.40% is 101% above its 5-year average of -74.47%, near the high end of its 5-year range (-1438.43%–6.51%).
104.25% above its 12-month average of -9.41%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -20.20%.
EBITDA MARGIN
0.40%
EBITDA MARGIN AVG TTM
-9.41%
EBITDA MARGIN AVG 3Y
-21.67%
EBITDA MARGIN AVG 5Y
-74.47%
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+104.25%
CURRENT VS 3Y AVG
+101.85%
CURRENT VS 5Y AVG
+100.54%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Mirum Pharmaceuticals, Inc.
Market Cap
$4.90B
EBITDA Margin
0.40%
TTM Avg
-9.41%
3Y Avg
-21.67%
5Y Avg
-74.47%
Market Cap
$4.84B
EBITDA Margin
-30.33%
TTM Avg
-1782.03%
3Y Avg
-5492.00%
5Y Avg
-5492.00%
Market Cap
$4.81B
EBITDA Margin
-8718.32%
TTM Avg
-5172.73%
3Y Avg
-3124.55%
5Y Avg
-2649.58%
Market Cap
$5.06B
EBITDA Margin
21.06%
TTM Avg
20.50%
3Y Avg
18.63%
5Y Avg
16.67%
Market Cap
$4.66B
EBITDA Margin
5.54%
TTM Avg
4.34%
3Y Avg
-4.50%
5Y Avg
-6.75%
Market Cap
$4.64B
EBITDA Margin
7.23%
TTM Avg
7.47%
3Y Avg
7.86%
5Y Avg
7.54%
Market Cap
$4.62B
EBITDA Margin
9.15%
TTM Avg
-7.04%
3Y Avg
-33.99%
5Y Avg
-33.99%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | $4.90B | 0.40% | -9.41% | -21.67% | -74.47% |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.84B | -30.33% | -1782.03% | -5492.00% | -5492.00% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.81B | -8718.32% | -5172.73% | -3124.55% | -2649.58% |
| Erasca, Inc. (ERAS)vs › | $5.02B | N/A | N/A | N/A | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.06B | 21.06% | 20.50% | 18.63% | 16.67% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.69B | N/A | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.66B | 5.54% | 4.34% | -4.50% | -6.75% |
| Option Care Health, Inc. (OPCH)vs › | $4.64B | 7.23% | 7.47% | 7.86% | 7.54% |
| BillionToOne, Inc. (BLLN)vs › | $4.62B | 9.15% | -7.04% | -33.99% | -33.99% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.18B | -395.82% | -536.17% | -471.62% | -471.62% |
Gross Margin
81.7%
EBITDA Margin
0.4%
Operating Margin
-4.3%
Net Margin
-139.2%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -20.20% |
| 2026-03-31 | -35.21% |
| 2025-12-31 | 1.01% |
| 2025-09-30 | 6.51% |
| 2025-06-30 | 0.83% |
| 2025-03-31 | -8.18% |
| 2024-12-31 | -18.27% |
| 2024-09-30 | -7.33% |
| 2024-06-30 | -23.60% |
| 2024-03-31 | -30.05% |
| 2023-12-31 | -38.95% |
| 2023-09-30 | -47.12% |
| 2023-06-30 | -61.17% |
| 2023-03-31 | -81.69% |
| 2022-12-31 | -117.65% |
| 2022-09-30 | -169.25% |
| 2022-06-30 | -175.80% |
| 2022-03-31 | -250.49% |
| 2021-12-31 | -1438.43% |
| 2021-09-30 | -852.92% |
| 2021-06-30 | -338.42% |
